Ex vivo assessment of drug response by differential staining cytotoxicity (DiSC) assay suggests a biological basis for equality of chemotherapy irrespective of age for patients with chronic lymphocytic leukaemia

Leukemia

Volumn 14, Issue 4, 2000, Pages 712-715

  Bosanquet, A G ^a,b   Bosanquet, M I ^a,b  

^a ROYAL UNITED HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BATH   (United Kingdom)

Author keywords

Age; Cellular sensitivity; Chronic lymphocytic leukaemia; Cytotoxic; DiSC assay

Indexed keywords

ANTILEUKEMIC AGENT; CHLORAMBUCIL; CLADRIBINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUDARABINE; MAFOSFAMIDE; METHYLPREDNISOLONE; PENTOSTATIN; PREDNISOLONE; VINCRISTINE;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0034091153     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401727     Document Type: Article

References (28)

1. Fentiman IS, Tirelli U, Monfardini S, Schneider M, Festen J, Cognetti F, Aapro MS. Cancer in the elderly: why so badly treated? Lancet 1990; 335: 1020-1022.
2. Maung ZT, Reid MM, Matheson E, Taylor PR, Proctor SJ, Hall AG. Corticosteroid resistance is increased in lymphoblasts from adults compared with children: preliminary results of in vitro drug sensitivity study in adults with acute lymphoblastic leukaemia. Br J Haematol 1995; 91: 93-100.
3. Pieters R, den Boer ML, Durian M, Janka G, Schmiegelow K, Kaspers GJ, van Wering ER, Veerman AJ. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia - implications for treatment of infants. Leukemia 1998; 12: 1344-1348.
4. Leith CP, Kopecky KJ, Godwin J, McConnell T, Slovak ML, Chen IM, Head DR, Appelbaum FR, Willman CL. Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood 1997; 89: 3323-3329.
5. Stewart AK, Huang C, Stollar BD, Schwartz RS. High-frequency representation of a single VH gene in the expressed human B cell repertoire. J Exp Med 1993; 177: 409-418.
6. Rozman C, Montserrat E. Chronic lymphocytic leukemia. New Engl J Med 1995; 333: 1052-1057.
7. Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. New Engl J Med 1999; 341: 2061-2067.
8. Bosanquet AG, Johnson SA, Richards SM. Prognosis for fludarabine therapy of chronic lymphocytic leukaemia based on ex vivo drug response by DiSC assay. Br J Haematol 1999; 106: 71-77.
9. Bosanquet AG, Copplestone JA, Johnson SA, Smith AG, Povey SJ, Orchard JA, Oscier DG. Response to cladribine in previously treated patients with chronic lymphocytic leukaemia identified by ex vivo assessment of drug sensitivity by DiSC assay. Br J Haematol 1999; 106: 474-476.
10. Bosanquet AG. Short-term in vitro drug sensitivity tests for cancer chemotherapy. A summary of correlations of test result with both patient response and survival. Forum Trends Exp Clin Med 1994; 4: 179-195.
11. Bosanquet AG, Bell PB. Enhanced ex vivo drug sensitivity testing of chronic: lymphocytic leukemia using refined DiSC assay methodology. Leukemia Res 1996; 20: 143-153.
12. Bosanquet AG, Burlton AR, Bell PB. Parameters affecting the ex vivo cytotoxic drug sensitivity of human haematopoietic cells. J Exp Ther Oncol (in press).
13. Fentiman IA. Are the elderly receiving appropriate treatment for cancer? Ann Oncol 1996; 7: 657-658.
14. Lichtman SM. Recent developments in the pharmacology of anticancer drugs in the elderly. Curr Opin Oncol 1998; 10: 572-579.
15. Mei N, Imada H, Nomoto S, Kunugita N, Norimura T. Individual variation and age dependency in the radiosensitivity of peripheral blood T-lymphocytes from normal donors. J Radiat Res 1996; 37: 235-245.
16. Rowley JD. Molecular cytogenetics: Rosetta stone for understanding cancer. Cancer Res 1990; 50: 3816-3825.
17. Montserrat E, Gomis F, Vallespi T, Rios A, Romero A, Soler J, Alcala A, Morey M, Ferran C, Diaz-Mediavilla J. Presenting features and prognosis of chronic lymphocytic leukemia in younger adults. Blood 1991; 78: 1545-1551.
18. Gomez N, Hidalgo M, Casanova L, Colomer R, Pen DL, Otero J, Rodriguez W, Carracedo C, Cortes-Funes H, Vallejos C. Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis. J Clin Oncol 1998; 16: 2065-2069.
19. Lowenberg B, Zittoun R, Kerkhofs H, Jehn U, Abels J, Debusscher L, Cauchie C, Peetermans M, Solbu G, Suciu S. On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomised phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group. J Clin Oncol 1989; 7: 1268-1274.
20. Dighiero G, Travade P, Chevret S, Fenaux P, Chastang C, Binet JL. B-cell chronic lymphocytic leukaemia: present status and future directions. Blood 1991; 78: 1901-1914.
21. Montserrat E, Rozman C. Chronic lymphocytic leukemia: present status. Ann Oncol 1995; 6: 219-235.
22. The French Cooperative Group on CLL, Johnson S, Smith AG, Löffler H, Ösby, E, Juliusson G, Emmerich B, Wyld PJ, Hiddemann W. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. Lancet 1996; 347: 1432-1438.
23. Bosanquet AG. Correlations between therapeutic response of leukaemias and in vitro drug sensitivity assay. Lancet 1991; 337: 711-714.
24. Greenfield S, Bianco DM, Elashoff RM, Ganz PA. Patterns of care related to age of breast cancer patients. J Am Med Assoc 1987; 257: 2766-2770.
25. Mason JM, Drummond MF, Bosanquet AG, Sheldon TA. The DiSC assay: a cost-effective guide to treatment for chronic lymphocytic leukemia? Int J Tech Assess Health Care 1999; 15: 173-184.
26. Tirelli U, Zagonel V, Serraino D, Thomas J, Hoerni B, Tangury A, Ruhl U, Bey P, Tubiana N, Breed WP. Non-Hodgkin's lymphomas in 137 patients aged 70 years or older: a retrospective EORTC lymphoma group study. J Clin Oncol 1988; 11: 1708-1713.
27. McKenna RJ. Clinical aspects of cancer in the elderly. Treatment decisions, treatment choices and follow-up. Cancer 1994; 74: 2107-2117.
28. Balducci L, Phillips DM, Davis KM, Files JC, Khansur T, Hardy CL. Systemic treatment of cancer in the elderly. Arch Gerontol Geriatr 1988; 7: 119-150.